To interrogate this hypothesis, we first examined whether XIST RNA levels were associated with evidence of IFN production in the SLE target tissue using single-cell RNA-sequencing data from kidney-infiltrating immune cells in patients with lupus nephritis available through the Accelerating Medicines Partnership (AMP) (37). This evidence concerns the gene XIST and systemic lupus erythematosus.